Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA Grants Accelerated Approval For Alzheimer’s Disease Treatment

https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment
byBenzinga Newsdesk
January 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment

https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Is Home Furnishing Retailer Williams-Sonoma Stock Surging Today?

By Shivani Kumaresan
May 22, 9:36 AM
Williams-Sonoma shares soar as Q1 FY24 earnings surpass expectations. Despite a 6.5% sales decline to $1.66 billion, the company beat EPS estimates with $4.07 compared to $2.70. Gross margin expanded to 48.3%, and operating income surged 62.3% to $323.8 million. CEO Laura Alber emphasizes the company's commitment to growth, customer service, and margin improvement.

WSM